8ZM-68385-29612 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-13
Dose 1 — Janssen/Johnson & Johnson
2021-03-14
Registered in v-safe
2021-03-14
Survey response — days 1–6 daily, dose 1
MedDRA: Heart rate increased — Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea

Free text: Racing heartbeat in the middle of the night (100bpm)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-06-14
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2022-03-13
Health check-in — 12 months, dose 1
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-13	Janssen/Johnson & Johnson

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-14

Systemic reaction (other): Racing heartbeat in the middle of the night (100bpm)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Heart rate increased	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release